Works matching DE "MELANOMA immunotherapy"
Results: 101
TCR Gene Transfer:MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/586314
- By:
- Publication type:
- Article
Lessons from Cancer Immunoediting in Cutaneous Melanoma.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/192719
- By:
- Publication type:
- Article
Melanoma therapy with transdermal mitoxantrone cubic phases.
- Published in:
- Drug Delivery, 2016, v. 23, n. 5, p. 1565, doi. 10.3109/10717544.2015.1024898
- By:
- Publication type:
- Article
High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients.
- Published in:
- Pigment Cell & Melanoma Research, 2014, v. 27, n. 3, p. 454, doi. 10.1111/pcmr.12226
- By:
- Publication type:
- Article
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 4, p. E8, doi. 10.1111/pcmr.12099
- By:
- Publication type:
- Article
Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 3, p. 410, doi. 10.1007/s10147-018-1259-6
- By:
- Publication type:
- Article
Friends or foes: IL-10 and TGF- β in melanoma.
- Published in:
- Experimental Dermatology, 2015, v. 24, n. 4, p. 254, doi. 10.1111/exd.12661
- By:
- Publication type:
- Article
Dermoscopy of Naevus-associated Melanomas.
- Published in:
- Acta Dermato-Venereologica, 2015, v. 95, n. 6, p. 671, doi. 10.2340/00015555-2009
- By:
- Publication type:
- Article
Metastatic Melanoma -- A Review of Current and Future Treatment Options.
- Published in:
- Acta Dermato-Venereologica, 2015, v. 95, n. 5, p. 516, doi. 10.2340/00015555-2035
- By:
- Publication type:
- Article
Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
- Published in:
- Journal of Cancer Research & Therapeutics, 2013, v. 9, p. S160, doi. 10.4103/0973-1482.122516
- By:
- Publication type:
- Article
Organ conservation approach for primary mucosal malignant melanoma of the larynx.
- Published in:
- 2013
- By:
- Publication type:
- Letter to the Editor
Enhancement of electroporation facilitated immunogene therapy via T-reg depletion.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 8, p. 349, doi. 10.1038/cgt.2014.35
- By:
- Publication type:
- Article
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 10, p. 1359, doi. 10.1007/s00262-017-2030-y
- By:
- Publication type:
- Article
Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 299, doi. 10.1007/s00262-016-1939-x
- By:
- Publication type:
- Article
Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 5, p. 601, doi. 10.1007/s00262-016-1823-8
- By:
- Publication type:
- Article
Increasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 127, doi. 10.1007/s00262-015-1772-7
- By:
- Publication type:
- Article
Intratumoral immunotherapy for melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 7, p. 911, doi. 10.1007/s00262-015-1727-z
- By:
- Publication type:
- Article
Broadening the repertoire of melanoma-associated T-cell epitopes.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 609, doi. 10.1007/s00262-015-1664-x
- By:
- Publication type:
- Article
Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 3, p. 381, doi. 10.1007/s00262-014-1642-8
- By:
- Publication type:
- Article
Armed antibodies for cancer treatment: a promising tool in a changing era.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 113, doi. 10.1007/s00262-014-1621-0
- By:
- Publication type:
- Article
Fast-growing in-transit melanoma metastasis after intratumoral interleukin-2.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Limited efficacy of intratumoral IL-2 applied to large melanoma metastases.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 9, p. 959, doi. 10.1007/s00262-014-1558-3
- By:
- Publication type:
- Article
Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 7, p. 1187, doi. 10.1007/s00262-013-1423-9
- By:
- Publication type:
- Article
An immune-active tumor microenvironment favors clinical response to ipilimumab.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1019, doi. 10.1007/s00262-011-1172-6
- By:
- Publication type:
- Article
Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 1033, doi. 10.1007/s00262-011-1176-2
- By:
- Publication type:
- Article
American Association of Cancer Research Showcases Immunotherapy Advances.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 4, doi. 10.1093/jnci/djv231
- By:
- Publication type:
- Article
Quantitative Characterization of the Exposure-Response Relationship for Cancer Immunotherapy: A Case Study of Nivolumab in Patients With Advanced Melanoma.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 1, p. 5, doi. 10.1002/psp4.12131
- By:
- Publication type:
- Article
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 6, p. 1143, doi. 10.1002/cam4.1001
- By:
- Publication type:
- Article
Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.
- Published in:
- Scientific Reports, 2015, p. 11198, doi. 10.1038/srep11198
- By:
- Publication type:
- Article
A new era of proactive melanoma therapy: hit hard, hit early.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Progress in the diagnosis and therapy of melanoma.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules/papules.
- Published in:
- British Journal of Dermatology, 2017, v. 177, n. 5, p. 1442, doi. 10.1111/bjd.15499
- By:
- Publication type:
- Article
Prognostic and predictive biomarkers for the benefit of immunotherapy in patients with metastatic melanoma.
- Published in:
- British Journal of Dermatology, 2016, v. 174, n. 1, p. 20, doi. 10.1111/bjd.14251
- By:
- Publication type:
- Article
Immunotherapy in cancer: a combat between tumors and the immune system; you win some, you lose some.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00127
- By:
- Publication type:
- Article
Update on use of aldesleukin for treatment of high-risk metastatic melanoma.
- Published in:
- ImmunoTargets & Therapy, 2015, v. 4, p. 79, doi. 10.2147/ITT.S61590
- By:
- Publication type:
- Article
Somatic driver mutations in melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Molecular insights into melanoma brain metastases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interaction of molecular alterations with immune response in melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Immune and molecular correlates in melanoma treated with immune checkpoint blockade.
- Published in:
- 2017
- By:
- Publication type:
- journal article
New immunotherapies show promise in some patients: Physicians try to balance optimism with realistic expectations.
- Published in:
- 2015
- By:
- Publication type:
- Other
Highlights from the AACR annual meeting.
- Published in:
- 2014
- By:
- Publication type:
- Proceeding
Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 11, p. 1695, doi. 10.1002/cncr.28620
- By:
- Publication type:
- Article
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0262-6
- By:
- Publication type:
- Article
Advances in immunotherapy for melanoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 43, doi. 10.1007/s10555-017-9656-2
- By:
- Publication type:
- Article
BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 35, doi. 10.1007/s10555-017-9660-6
- By:
- Publication type:
- Article